Sample size
paresis
MINOR, PARESIS, SECONDARY
The required number of subjects has been determined to be 82, from preliminary data in literature: to our knowledge the sole RCT about rehabilitation in subacute/chronic stages of PFP (participants enrolled from 9 months into the onset of paresis) using SFGS included 50 participants, among whom only 24 benefited from rehabilitation (waiting list without any rehabilitation in the other group) [In contrast with that trial, participants of the control group of the present study will benefit from an intervention (physiotherapy and/or speech therapy), which will be associated with the potential to improve clinical status. We thus hypothesize that there will be a minor improvement of + 10 points in the Sunnybrook composite score in that group. Based on that hypothesis and to demonstrate an improvement of + 20 points (with a standard deviation up to 13) for the experimental group, considering a 5% alpha risk (bilateral test) and a statistical power of 90%, we will include 41 patients per group for 36 analyzed (assuming a 10% loss of follow-up).Regarding the secondary objectives, it should be noted that this sample size will be comparable to other reliability and validity studies for the FaCE scale (